lumbercar2
About
RE-MIND: Looking at tafasitamab + lenalidomide (L-MIND) using a real‑world lenalidomide monotherapy cohort throughout relapsed or perhaps refractory dissipate significant B-cell lymphoma.
RE-MIND: Looking at tafasitamab + lenalidomide (L-MIND) using a real‑world lenalidomide monotherapy cohort throughout relapsed or perhaps refractory dissipate significant B-cell lymphoma.